5 years for Kimbrel is far more likely than $30M AAV.
Jansen got 5/80 with an opt out after year 3. That is the starting point for Kimbrel negotiations, and teams will bid up from there. I imagine 5/100 is in play as a reasonable guess, especially if he doesn’t get an opt out.
He will get 5 years, and he will beat the $17.3M AAV Davis just got. That means 5/90 is likely the lowest contract he can be reasonably projected to sign...barring injury, of course.
Last edited by Enscheff; 12-30-2017 at 11:09 AM.
jpx7 (12-30-2017)
At what price would it make sense for the Braves? Lets assume a scenario where Kimbrel has desires to pitch back at home. What AAV over 4 years would make sense? 15?
Natural Immunity Croc
jpx7 (12-30-2017)
Its all about value. Would Kimbrels production over 4 years be worth a 60-70M investment? I think an argument for that could be made.
Not saying this is what I'd like to do because I do believe we have a pipeline of pitching that could be high leverage bullpen arms (Minter/Lindgren/Touki/Weigel/etc...) but it shouldn't be something that is ruled out if the price is right.
Natural Immunity Croc
Kimbrel is old. Do not pay for an old closer
We have minter Newcombe wiegel etc who could be very good for cheap.
If the braves can put 60 million plus in a closer then they should take that money and roll it into harpers 400 plus million
I don’t see us going after Kimbrel at any price. Prices for relievers are getting out of hand. If I were AA I’d be looking at the relievers being ignored next offseason as it is deep.
Because there is a huge crop of high end FA players next offseason, what is Machado likely to get or does it depend a ton on his 2018?
He hits FA at a very young age.
Ivermectin Man
Does it make sense that the Yankees and Dodgers have bent over backwards to reset their luxury tax penalties and will then be outbid by a mid-market team on the most valuable players to hit FA since...ARod?
Not to mention the Phils have waaaay more money than the Braves with almost zero payroll spent.